Abstract
A case of acquired hemophilia A in a 65-year-old woman is presented. The patient had been subjected to cholecystectomy 2 months before the bleeding tendency appeared. On admission, she had easy bruising and prolonged activated partial thromboplastin time, but during hospitalization she had severe hemorrhage into the right gluteal and femoral muscles. An inhibitor of the factor VIII coagulant protein (FVIII : C) of high Bethesda titer was found in her serum. The patient was successfully treated with activated recombinant human factor VII (rhFVIIa) and immunosuppression. We conclude that rhFVIIa is a safe, effective, and fast-acting preparation for the treatment of severe hemorrhage in patients with acquired hemophilia A, and that the simultaneous administration of azathioprine and corticosteroids may suppress production of the inhibitor.
Similar content being viewed by others
Author information
Authors and Affiliations
Additional information
Received: 10 February 1998 / Accepted: 9 April 1998
Rights and permissions
About this article
Cite this article
Papadaki, H., Xylouri, I., Valatas, W. et al. Severe acquired hemophilia A successfully treated with activated recombinant human factor VII. Ann Hematol 77, 123–125 (1998). https://doi.org/10.1007/s002770050426
Issue Date:
DOI: https://doi.org/10.1007/s002770050426